Coronary artery disease leading to myocardial infarction (“heart attack”) is a major cause of death worldwide . After a heart attack, the myocardium is unable to regenerate, therefore, the heart ...
Read More »EXOSOME NEWS
Evox Therapeutics completes £69.2 million Series C financing
Financing round significantly oversubscribed by both new and existing investors Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome...
Read More »Upcoming Webinar – Exosome and Exomere Biomarkers for Early Cancer Detection
Speaker David Lyden, M.D., Ph.D. Stavros S. Niarchos Professor in Pediatric Cardiology Professor of Pediatrics Cornell University
Read More »Magnetic Colloid Antibodies Accelerate Small Extracellular Vesicles Isolation for Point-of-Care Diagnostics
Small extracellular vesicles (sEVs) are increasingly recognized as noninvasive diagnostic markers for many diseases. Hence, it is highly desirable to isolate sEVs rapidly for downstream molecular analyses. However, conventional methods ...
Read More »Ciloa’s project based on exosomes customization is among the 11 winners of the “Sanofi iTech Awards”
Ciloa, a pioneer company specialized in the in vivo customization of exosomes, announced today the selection of its project as part of the “Sanofi iTech Awards” program. It is the first time that ...
Read More »VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics
VivaZome Therapeutics and La Trobe University announced that they have entered into a new collaborative research project focused on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will ...
Read More »A comparison of extracellular vesicles and synthetic nanoparticles for RNA delivery
RNA therapeutics have high potential that is yet to be fully realized, largely due to challenges involved in the appropriate delivery to target cells...
Read More »Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock
Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics a...
Read More »Jobs
-
Doctoral thesis research position available – Extracellular Vesicles and the Blood-Brain Barrier
The Austrian Institute of Technology is Austria’s largest research and technology organisation and an international player in applied research for...
Read More » -
Featured Exosome Job – Scientist, Translational Biology
-
Featured Exosome Job – Vice President, Head of Analytical Development
-
Featured Exosome Job – facilitate the intracellular delivery and extracellular transport of gene modulating and editing technologies
-
Featured exosome job – Programmer/Analyst supporting the Extracellular RNA Communications Consortium
Industry News
-
Regenasome is seeking to raise a Series A of USD10m
Researchers at Monash University and the Hudson Institute have developed an exosome therapy to treat IPF and formed the spinout company Regenasome. Exosomes are nano-vesicles...
Read More » -
Evox Therapeutics completes £69.2 million Series C financing
-
Ciloa’s project based on exosomes customization is among the 11 winners of the “Sanofi iTech Awards”
-
VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics
-
Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock